Redwood Wealth Management Group, LLC Taysha Gene Therapies, Inc. Transaction History

Redwood Wealth Management Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$2.04 - $4.17 $94,656 - $193,488	46,400 New	46,400 $104 Million
Q4 2023 Jan 25, 2024	BUY	$1.33 - $2.88 $5,852 - $12,672	4,400 Added 11.52%	42,600 $75.4 Million
Q3 2023 Oct 18, 2023	BUY	$0.63 - $3.66 $94 - $549	150 Added 0.39%	38,200 $121 Million
Q2 2023 Jul 20, 2023	BUY	$0.59 - $0.87 $177 - $261	300 Added 0.79%	38,050 $25.2 Million
Q1 2023 Apr 19, 2023	BUY	$0.65 - $2.3 $1,397 - $4,945	2,150 Added 6.04%	37,750 $30.1 Million
Q4 2022 Feb 01, 2023	BUY	$1.39 - $2.98 $49,484 - $106,088	35,600 New	35,600 $80.5 Million

119

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $103M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Redwood Wealth Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Wealth Management Group, LLC with notifications on news.